Day: January 24, 2022

RWE Alliance Submits Comments on FDA’s RWE Draft Guidance, Highlights Recommendations for Agency’s RWE Program and RWE Derived from EHR/Claims Data

WASHINGTON--(BUSINESS WIRE)--Today, the RWE Alliance submitted a substantial comment letter in response to the U.S. Food and Drug Administration (FDA)...

United States Data Center Market Outlook & Forecast Report 2022-2027 Featuring Key Vendors – Athenahealth, Cerner, DrFirst, Henry Schein, InSync Healthcare Solutions, Practice Fusion & Surescripts – ResearchAndMarkets.com

Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2022 ASCO GI Meeting

error: Content is protected !!